Taken together, these results suggested that LIMK1 is correlated with lymph node metastases and high TNM stage, further suggesting LIMK1 may act as a biomarker of poor prognosis for lung adenocarcinoma. This evidence concerns the gene LIMK1 and lung adenocarcinoma.